Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
12.72
+0.25 (2.00%)
Mar 10, 2026, 2:44 PM HKT
HKG:1858 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 1,140 | 1,266 | 957.19 | 1,736 | Upgrade
|
| Trading Asset Securities | - | 745.8 | 832.02 | 767.73 | - | Upgrade
|
| Cash & Short-Term Investments | 1,995 | 1,886 | 2,098 | 1,725 | 1,736 | Upgrade
|
| Cash Growth | 5.82% | -10.14% | 21.65% | -0.67% | 151.68% | Upgrade
|
| Accounts Receivable | - | 378.71 | 441.72 | 767.39 | 527.79 | Upgrade
|
| Other Receivables | - | 17.46 | 18.61 | 13.5 | 4.49 | Upgrade
|
| Receivables | - | 396.17 | 460.33 | 780.89 | 532.28 | Upgrade
|
| Inventory | - | 550.84 | 434.49 | 259.79 | 159.68 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 0.01 | Upgrade
|
| Other Current Assets | - | 7.89 | 12.16 | 13.49 | 19.3 | Upgrade
|
| Total Current Assets | - | 2,840 | 3,005 | 2,779 | 2,448 | Upgrade
|
| Property, Plant & Equipment | - | 468.8 | 465.13 | 465.27 | 394.75 | Upgrade
|
| Goodwill | - | - | 13.36 | - | - | Upgrade
|
| Other Intangible Assets | - | 127.57 | 136.27 | 138.17 | 131.97 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 26.11 | 27.63 | 25.76 | 22.88 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.13 | Upgrade
|
| Other Long-Term Assets | - | 2.77 | 1.8 | 1.48 | 2.16 | Upgrade
|
| Total Assets | - | 3,466 | 3,650 | 3,410 | 3,000 | Upgrade
|
| Accounts Payable | - | 227.85 | 225.5 | 237.79 | 77.66 | Upgrade
|
| Accrued Expenses | - | 74.17 | 149.71 | 120.81 | 122.48 | Upgrade
|
| Current Portion of Leases | - | 0.68 | 1.22 | 0.69 | 1.23 | Upgrade
|
| Current Income Taxes Payable | - | 0.94 | 12.13 | 10.88 | 10.16 | Upgrade
|
| Current Unearned Revenue | - | 128.56 | 149.56 | 85.68 | 59.54 | Upgrade
|
| Other Current Liabilities | - | 114.55 | 138.55 | 139.96 | 168.54 | Upgrade
|
| Total Current Liabilities | - | 546.75 | 676.67 | 595.8 | 439.62 | Upgrade
|
| Long-Term Leases | - | 0.18 | 0.53 | 0.63 | - | Upgrade
|
| Long-Term Unearned Revenue | - | 86.75 | 83.79 | 85.76 | 85.56 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 10.71 | 9.33 | 7.88 | 5.4 | Upgrade
|
| Total Liabilities | - | 644.39 | 770.33 | 690.07 | 530.58 | Upgrade
|
| Common Stock | - | 383.57 | 383.57 | 384.28 | 384.28 | Upgrade
|
| Additional Paid-In Capital | - | 1,045 | 1,045 | 1,051 | 1,051 | Upgrade
|
| Retained Earnings | - | 1,404 | 1,449 | 1,291 | 1,034 | Upgrade
|
| Treasury Stock | - | -12.02 | - | -7.14 | - | Upgrade
|
| Total Common Equity | 2,985 | 2,820 | 2,877 | 2,720 | 2,469 | Upgrade
|
| Minority Interest | - | 1.44 | 1.77 | - | - | Upgrade
|
| Shareholders' Equity | 2,986 | 2,821 | 2,879 | 2,720 | 2,469 | Upgrade
|
| Total Liabilities & Equity | - | 3,466 | 3,650 | 3,410 | 3,000 | Upgrade
|
| Total Debt | 0.22 | 0.87 | 1.75 | 1.31 | 1.23 | Upgrade
|
| Net Cash (Debt) | 1,995 | 1,885 | 2,097 | 1,724 | 1,735 | Upgrade
|
| Net Cash Growth | 5.86% | -10.11% | 21.64% | -0.67% | 152.17% | Upgrade
|
| Net Cash Per Share | 5.21 | 4.98 | 5.43 | 4.48 | 5.01 | Upgrade
|
| Filing Date Shares Outstanding | 383.91 | 382.7 | 383.57 | 383.57 | 384.28 | Upgrade
|
| Total Common Shares Outstanding | 383.91 | 382.7 | 383.57 | 383.57 | 384.28 | Upgrade
|
| Working Capital | - | 2,294 | 2,329 | 2,183 | 2,008 | Upgrade
|
| Book Value Per Share | 7.81 | 7.37 | 7.50 | 7.09 | 6.43 | Upgrade
|
| Tangible Book Value | 2,863 | 2,692 | 2,728 | 2,582 | 2,337 | Upgrade
|
| Tangible Book Value Per Share | 7.49 | 7.04 | 7.11 | 6.73 | 6.08 | Upgrade
|
| Buildings | - | 223.09 | 223.04 | 184.58 | 31.31 | Upgrade
|
| Machinery | - | 224.08 | 200.27 | 179.96 | 146.51 | Upgrade
|
| Construction In Progress | - | 156.78 | 150.14 | 185.1 | 281.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.